Kymera Therapeutics DPO Ratio 2011-2026 | KYMR

Annual DPO Ratio Kymera Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
46.6	50.6	26.5	32.5	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
50.6	26.5	39.1

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
186	63.8	33.5	-	159	23.7	61.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
186	23.7	87.9

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Nymox Pharmaceutical Corporation NYMX	2.41 K	-	-19.68 %	$ 18.4 M	Canada
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	405	$ 0.9	-2.33 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	75.2	$ 21.96	-0.68 %	$ 3.64 B	USA
RedHill Biopharma Ltd. RDHL	22.9	$ 1.02	-0.49 %	$ 428 M	Israel
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	31.7	$ 21.41	1.9 %	$ 1 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aquestive Therapeutics AQST	395	$ 4.08	0.25 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	133	$ 23.26	1.75 %	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.44	-5.88 %	$ 383 M	Britain
BioXcel Therapeutics BTAI	34.2 K	$ 1.06	-3.64 %	$ 12.9 M	USA
CASI Pharmaceuticals CASI	123	-	-	$ 35.4 M	USA
bluebird bio BLUE	182	-	-	$ 546 M	USA